| Views | |
|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 46 |
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 4 | 4 | 11 | 4 | 5 |
| Views | |
|---|---|
| Gruzdeva_Risk management.pdf | 27 |
| Views | |
|---|---|
| Canada | 10 |
| United States | 10 |
| Australia | 2 |
| India | 2 |
| Japan | 2 |
| Brazil | 1 |
| China | 1 |
| United Kingdom | 1 |
| Russia | 1 |
| South Africa | 1 |
| Views | |
|---|---|
| Ottawa | 10 |
| Englewood | 3 |
| Kanda | 2 |
| Mumbai | 2 |
| San Jose | 2 |
| Birmingham | 1 |
| Dearborn | 1 |
| Durham | 1 |
| Geelong | 1 |
| Goiânia | 1 |